From: D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer
Variable | No of case | CTC-positive (%) | D-dimer | CEA |
---|---|---|---|---|
Gender | ||||
Male | 34 | 10 (29.41%) | 1.10 (0.58–2.35) | 2.80 (1.58–19.53) |
Female | 7 | 3 (42.85%) | 1.30 (0.50–3.30) | 4.21 (1.63–19.46) |
Age | ||||
≤ 61 | 19 | 7 (36.84%) | 1.30 (0.50–3.50) | 2.79 (1.38–19.46) |
>61 | 22 | 6 (27.27%) | 1.05 (0.70–1.77) | 3.15 (1.70–10.25) |
Histological Grade | ||||
G1–G2 | 14 | 4 (28.57%) | 0.85 (0.48–1.62) | 4.27 (2.92–25.30) |
G3–G4 | 27 | 9 (33.33%) | 1.30 (0.70–3.30) | 2.25 (1.38–5.46) |
TNM Stage | ||||
IIIB | 11 | 0 | 0.50 (0.30–1.10) | 4.34 (2.16–19.46) |
IV | 30 | 13 | 1.50 (0.87–3.35) | 2.43 (1.58–10.25) |
Metastasis | ||||
M0 | 20 | 3 | 0.95 (0.50–1.65) | 2.60 (1.39–14.59) |
M1 | 16 | 6 | 1.10 (0.62–2.12) | 2.99 (1.78–39.44) |
M2 | 5 | 4 | 7.10 (2.45–26.80) | 4.70 (1.56–64.81) |
Surgery | ||||
R0 | 20 | 3 | 1.00 (0.35–1.65) | 2.50 (1.39–4.76) |
R1 | 15 | 7 | 1.60 (0.70–3.80) | 2.96 (1.63–17.83) |
Other | 6 | 2 | 1.40 (0.80–9.35) | 28.11 (2.40–157.25) |